Hunan Fangsheng Pharmaceutical Co Ltd
SSE:603998

Watchlist Manager
Hunan Fangsheng Pharmaceutical Co Ltd Logo
Hunan Fangsheng Pharmaceutical Co Ltd
SSE:603998
Watchlist
Price: 10.67 CNY -4.05% Market Closed
Market Cap: 4.7B CNY

EV/EBITDA
Enterprise Value to EBITDA

19.3
Current
22.5
Median
12.8
Industry
Lower than median
Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
19.3
=
Enterprise Value
5.1B CNY
/
EBITDA
267.1m CNY

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
11
2-Years Forward
EV/EBITDA
9.5
3-Years Forward
EV/EBITDA
8.3